CellCept bør gives med forsigtighed til patienter svær, aktiv sygdom i fordøjelsessystemet.
Because CellCept has been associated with an increased incidence of digestive system adverse events, including infrequent cases of gastrointestinal tract ulceration, haemorrhage and perforation, CellCept should be administered with caution in patients with active serious digestive system disease.